Xtant Medical to Issue First Quarter 2024 Financial Results on May 15, 2024
Xtant Medical to Issue First Quarter 2024 Financial Results on May 15, 2024
BELGRADE, MO / ACCESSWIRE / May 8, 2024 / Xtant Medical Holdings, Inc. (NYSE American:XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its financial results for the first quarter ended March 31, 2024, after the close of the financial markets on Wednesday, May 15, 2024.
密蘇里州貝爾格萊德/ACCESSWIRE/2024年5月8日/專注於脊柱疾病手術解決方案的全球醫療技術公司Xtant Medical Holdings, Inc.（紐約證券交易所美國股票代碼：XTNT）今天宣佈，將在2024年5月15日星期三金融市場收盤後發佈截至2024年3月31日的第一季度財務業績。
Sean Browne, President and Chief Executive Officer, and Scott Neils, Chief Financial Officer, will host a conference call on Wednesday, May 15 at 4:30 PM ET to review results.
總裁兼首席執行官肖恩·布朗和首席財務官斯科特·尼爾斯將於美國東部時間5月15日星期三下午 4:30 主持電話會議，審查業績。
Conference Details:
Conference Date: Wednesday, May 15, 2024
Conference Time: 4:30 PM ET
Conference dial-in: 877-545-0523
International dial-in: 973-528-0016
Passcode: 693614
Conference Call Name: Xtant Medical Q1 2024 Financial Results
Webcast Link:
會議詳情：
會議日期：2024 年 5 月 15 日星期三
會議時間：美國東部時間下午 4:30
會議撥入：877-545-0523
國際撥號：973-528-0016
密碼：693614
電話會議名稱：Xtant Medical 2024 年第一季度財務業績
網絡直播鏈接：
Following the live call, a replay will be available on the Company's website, under "Investor Info."
直播結束後，將在公司網站上的 “投資者信息” 下方重播。
About Xtant Medical Holdings, Inc.
Xtant 醫療控股公司簡介
Xtant Medical's mission of honoring the gift of donation so that our patients can live as full and complete a life as possible, is the driving force behind our company. Xtant Medical Holdings, Inc. ( is a global medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Xtant people are dedicated and talented, operating with the highest integrity to serve our customers.
Xtant Medical的使命是兌現捐贈的禮物，使我們的患者能夠過上儘可能充實的生活，這是我們公司的推動力。Xtant Medical Holdings, Inc.（是一家全球醫療技術公司，專注於設計、開發和商業化全面的矯形劑和脊柱植入系統產品組合，以促進複雜脊柱、畸形和退行性手術中的脊柱融合。Xtant 員工敬業且才華橫溢，以最高的誠信經營爲客戶服務。
The symbols and denote trademarks and registered trademarks of Xtant Medical Holdings, Inc. or its affiliates, registered as indicated in the United States, and in other countries. All other trademarks and trade names referred to in this release are the property of their respective owners.
這些符號和表示在美國和其他國家註冊的 Xtant Medical Holdings, Inc. 或其關聯公司的商標和註冊商標。本新聞稿中提及的所有其他商標和商品名稱均爲其各自所有者的財產。
Investor Relations Contact
投資者關係聯繫人
Brett Maas • Managing Partner, Hayden IR
brett@haydenir.com • (646) 536-7331
Brett Maas • Hayden IR 管理合夥人
brett@haydenir.com • (646) 536-7331
SOURCE: Xtant Medical Holdings, Inc.
來源：Xtant Medical Holdings, Inc.
譯文內容由第三人軟體翻譯。